Cairo University Hospitals, Kasr Al-Ainy
Cairo, Egypt
NCT Number: NCT07537270
This study is a three-arm, assessor-blinded, randomized controlled pilot feasibility trial. The primary goal is to evaluate the feasibility and acceptability of conducting a full-scale randomized controlled trial (RCT) comparing two manual therapy techniques: Manual Neural Mobilization (MNM) and Cervical Neuromodulatory Intervention (CNI) in individuals with Diabetic Peripheral Neuropathy (DPN).
While glycemic control is a central part of managing type 2 diabetes, this study explores whether non-pharmacological manual therapies can serve as adjunctive interventions to improve metabolic outcomes. A total of 75 participants were assigned to either MNM, CNI, or standard care for 12 weeks. The study focuses on recruitment rates, adherence, and safety, while also exploring secondary outcomes like blood glucose levels (HbA1c, FBG) and pain intensity.
This study is active but is not currently recruiting participants.
18 year–65 year
All sexes
Interventional
Not applicable
Cairo, Egypt
Background:
Diabetic peripheral neuropathy (DPN) often leads to pain and reduced quality of life. Manual therapy techniques such as Manual Neural Mobilization (MNM) and Cervical Neuromodulatory Intervention (CNI) are typically used for musculoskeletal relief, but their impact on systemic glycemic control in DPN patients is not yet well-established.
Objectives:
To assess the feasibility of the trial protocol (recruitment, retention, and adherence).
To provide preliminary data on the effects of MNM and CNI on glycemic parameters (HbA1c, FBG) and clinical symptoms (pain intensity, functional mobility).
Methodology:
Participants (n=75) with type 2 diabetes and clinically confirmed DPN were randomized into three equal groups:
Group 1 (MNM): Received manual neural mobilization targeting the lower limbs (2 sessions/week for 12 weeks).
Group 2 (CNI): Received cervical neuromodulatory techniques aimed at influencing the autonomic nervous system (2 sessions/week for 12 weeks).
Group 3 (Control): Received standard medical and physiotherapy care.
Outcome Assessment:
Feasibility was measured by tracking recruitment success and participant retention. Secondary exploratory outcomes included laboratory tests for HbA1c and Fasting Blood Glucose, and clinical scales for pain (VAS) and quality of life (SF-36). As this is a pilot study, the results are intended to inform the design and sample size of future definitive trials rather than to establish final clinical efficacy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Manual neural mobilization techniques were applied to improve neural mobility and reduce mechanosensitivity in the lower extremities. Treatment sessions were conducted twice weekly over a 12-week period.
Cervical neuromodulatory techniques were applied at the cervical spine to modulate neural function and potentially influence systemic outcomes. Sessions were conducted twice weekly for 12 weeks.
Participants continued to receive usual care as prescribed, including routine medical management and general physiotherapy advice.
Time frame: 3 months
Description: The average number of participants recruited per month during the recruitment period.
Time frame: 12 weeks
Description: The percentage of participants who complete the final assessment at 12 weeks relative to the number of participants randomized.
Time frame: Baseline, 6 weeks, and 12 weeks
Description: Participants rate their pain on a scale from 0 to 10, where 0 represents "no pain" and 10 represents "worst imaginable pain". Lower scores indicate a better outcome (reduction in pain).
Time frame: Baseline and 12 weeks
The Short Form-36 (SF-36) scores range from 0 to 100. Higher scores represent better physical and mental health status.
Time frame: Baseline and 12 weeks
FBG will be measured using venous blood samples to assess metabolic control.
Abeer Abdrabo
Other
Manual Neural Mobilization Versus Cervical Neuromodulatory Intervention for Glycemic Control in Adults With Diabetic Peripheral Neuropathy: Pilot RCT - Hypothesis-generating Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07675720
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Rawalpindi, Pakistan
View Trial DetailsNCT06688708
Diabetic Peripheral Neuropathy Type 2
Ongkharak, Changwat Nakhon Nayok, Thailand
View Trial DetailsNCT06544876
Diabetic Peripheral Neuropathy, Diabetic Peripheral Neuropathy Type 2
Austin, Texas, United States
View Trial Details